Advertisement

Reactions Weekly

, Volume 1732, Issue 1, pp 93–93 | Cite as

Bosutinib/dasatinib/imatinib

Development of drug resistance: case report
Case report
  • 28 Downloads

Reference

  1. Mikhailov I. BCR-ABL exon 7 deletion and novel point mutation in patient with chronic myelogenous leukemia and TKI resistance. Clinical Case Reports 6: 2057-2060, No. 11, Nov 2018. Available from: URL: http://doi.org/10.1002/ccr3.1794 - RussiaCrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations